📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial (2020)

First Author: Fitzgerald R

Attributed to: Oesophago-gastric adenocarcinoma: understanding disease pathogenesis and applications to earlier diagnosis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(20)31099-0

PubMed Identifier: 32738955

Publication URI: http://europepmc.org/abstract/MED/32738955

Type: Journal Article/Review

Parent Publication: The Lancet

Issue: 10247

ISSN: 0140-6736